agilon health, inc. (AGL)
NYSE: AGL · Real-Time Price · USD
0.3843
+0.0306 (8.65%)
Feb 18, 2026, 1:37 PM EST - Market open
agilon health Income Statement
Financials in millions USD. Fiscal year is January - December.
Millions USD. Fiscal year is Jan - Dec.
Fiscal Year | TTM | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 |
|---|---|---|---|---|---|---|
Period Ending | Sep '25 Sep 30, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 | Dec '20 Dec 31, 2020 |
Operating Revenue | 5,874 | 6,048 | 4,307 | 2,385 | 1,518 | 1,214 |
Other Revenue | 11.97 | 12.82 | 9.01 | 3.33 | 3.17 | 4.06 |
| 5,886 | 6,061 | 4,316 | 2,388 | 1,521 | 1,218 | |
Revenue Growth (YoY) | 5.21% | 40.41% | 80.74% | 56.96% | 24.88% | 53.36% |
Cost of Revenue | 5,993 | 6,056 | 4,247 | 2,277 | 1,456 | 1,124 |
Gross Profit | -107.61 | 4.84 | 69.67 | 111.36 | 65.74 | 94.15 |
Selling, General & Admin | 233.61 | 264.34 | 285.57 | 205.32 | 422.1 | 137.29 |
Operating Expenses | 261.73 | 288.8 | 301.62 | 214.27 | 432.59 | 150.82 |
Operating Income | -369.34 | -283.96 | -231.95 | -102.91 | -366.84 | -56.67 |
Interest Expense | -6.5 | -6.18 | -6.66 | -4.48 | -6.15 | -8.14 |
Interest & Investment Income | 16 | 19.2 | 27.9 | 14.5 | - | - |
Earnings From Equity Investments | 28.52 | 14.99 | 16.49 | 10.72 | -6.77 | 0.51 |
Other Non Operating Income (Expenses) | 18.28 | 15.29 | -0.06 | -0.57 | 2.18 | 1.95 |
EBT Excluding Unusual Items | -313.04 | -240.65 | -194.27 | -82.74 | -377.58 | -62.34 |
Asset Writedown | -3.6 | -3.6 | - | - | - | - |
Other Unusual Items | -4.58 | -4.58 | -0.19 | -7.93 | -5.4 | - |
Pretax Income | -321.21 | -248.83 | -194.46 | -90.67 | -382.98 | -62.34 |
Income Tax Expense | 1.68 | 1.45 | 0.79 | 1.64 | 0.89 | 0.87 |
Earnings From Continuing Operations | -322.9 | -250.28 | -195.25 | -92.31 | -383.86 | -63.21 |
Earnings From Discontinued Operations | 14.64 | -9.82 | -67.55 | -14.55 | -22.93 | 3.16 |
Net Income to Company | -308.26 | -260.1 | -262.8 | -106.86 | -406.79 | -60.05 |
Minority Interest in Earnings | - | -0.05 | 0.21 | 0.31 | 0.3 | - |
Net Income | -308.26 | -260.15 | -262.6 | -106.55 | -406.49 | -60.05 |
Net Income to Common | -308.26 | -260.15 | -262.6 | -106.55 | -406.49 | -60.05 |
Shares Outstanding (Basic) | 413 | 411 | 409 | 408 | 373 | 323 |
Shares Outstanding (Diluted) | 413 | 411 | 409 | 408 | 373 | 323 |
Shares Change (YoY) | 1.35% | 0.50% | 0.19% | 9.45% | 15.29% | 9.75% |
EPS (Basic) | -0.75 | -0.63 | -0.64 | -0.26 | -1.09 | -0.19 |
EPS (Diluted) | -0.75 | -0.63 | -0.65 | -0.26 | -1.09 | -0.19 |
Free Cash Flow | -82.35 | -71.03 | -172.03 | -146.23 | -154.72 | -54.98 |
Free Cash Flow Per Share | -0.20 | -0.17 | -0.42 | -0.36 | -0.41 | -0.17 |
Gross Margin | -1.83% | 0.08% | 1.61% | 4.66% | 4.32% | 7.73% |
Operating Margin | -6.28% | -4.69% | -5.37% | -4.31% | -24.11% | -4.65% |
Profit Margin | -5.24% | -4.29% | -6.08% | -4.46% | -26.72% | -4.93% |
Free Cash Flow Margin | -1.40% | -1.17% | -3.99% | -6.12% | -10.17% | -4.51% |
EBITDA | -341.22 | -259.49 | -215.9 | -93.96 | -356.36 | -43.14 |
EBITDA Margin | -5.80% | -4.28% | -5.00% | -3.93% | -23.42% | -3.54% |
D&A For EBITDA | 28.12 | 24.46 | 16.04 | 8.95 | 10.48 | 13.53 |
EBIT | -369.34 | -283.96 | -231.95 | -102.91 | -366.84 | -56.67 |
EBIT Margin | -6.28% | -4.69% | -5.37% | -4.31% | -24.11% | -4.65% |
Revenue as Reported | 5,886 | 6,061 | 4,316 | 2,388 | 1,521 | 1,218 |
Updated Nov 4, 2025. Source: S&P Global Market Intelligence. Standard template. Financial Sources.